The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Petasites hybridus root (butterbur) is an effective preventive treatment for migraine
Abstract
OBJECTIVE: To evaluate the clinical efficacy of a standardized special root extract from the plant Petasites hybridus as a preventive therapy for migraine. METHODS: This is a three-arm, parallel-group, randomized trial comparing Petasites extract 75 mg bid, Petasites extract 50 mg bid, or placebo bid in 245 patients with migraine. Eligible patients met International Headache Society criteria for migraine, were ages 18 to 65, and had at least two to six attacks per month over the preceding 3 months. The main outcome measure was the decrease in migraine attack frequency per month calculated as percentage change from baseline over a 4-month treatment period. RESULTS: Over 4 months of treatment, in the per-protocol analysis, migraine attack frequency was reduced by 48% for Petasites extract 75 mg bid (p = 0.0012 vs placebo), 36% for Petasites extract 50 mg bid (p = 0.127 vs placebo), and 26% for the placebo group. The proportion of patients with a > or =50% reduction in attack frequency after 4 months was 68% for patients in the Petasites extract 75-mg arm and 49% for the placebo arm (p < 0.05). Results were also significant in favor of Petasites 75 mg at 1, 2, and 3 months based on this endpoint. The most frequently reported adverse reactions considered possibly related to treatment were mild gastrointestinal events, predominantly burping. CONCLUSIONS: Petasites extract 75 mg bid is more effective than placebo and is well tolerated as a preventive therapy for migraine. Petasites 50 mg PO bid was not significantly more effective than placebo on the primary study endpoints.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sorge, F., Simone, R. D., Marano, E., Nolano, M., Orefice, G., & Carrieri, P. (1988) · Cephalalgia · doi:10.1046/j.1468-2982.1988.0801001.x · Cited by 3,465
Silberstein, S. D. (2000) · Neurology · doi:10.1212/wnl.55.6.754 · Cited by 1,360
Wolff’s Headache and Other Head Pain
(2009) · Archives of Neurology · doi:10.1001/archneurol.2009.17 · Cited by 589
Effectiveness of high‐dose riboflavin in migraine prophylaxis A randomized controlled trial
Schoenen, J., Jacquy, J., & Lenaerts, M. (1998) · Neurology · doi:10.1212/wnl.50.2.466 · Cited by 548
Peikert, A., Wilimzig, C., & Köhne-Volland, R. (1996) · Cephalalgia · doi:10.1046/j.1468-2982.1996.1604257.x · Cited by 364
Efficacy of Gabapentin in Migraine Prophylaxis
Mathew, N. T., Rapoport, A., Saper, J., Magnus, L., Klapper, J., Ramadan, N., Stacey, B., & Tepper, S. (2001) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.111006119.x · Cited by 343
Migraine Prophylaxis With Divalproex
Mathew, N. T., Saper, J. R., Silberstein, S. D., Rankin, L., Markley, H. G., Solomon, S., Rapoport, A. M., Silber, C. J., & Deaton, R. L. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540270077022 · Cited by 329
Efficacy of feverfew as prophylactic treatment of migraine.
Johnson, E. S., Kadam, N. P., Hylands, D. M., & Hylands, P. J. (1985) · BMJ · doi:10.1136/bmj.291.6495.569 · Cited by 273
Topiramate in Migraine Prevention: A Double‐Blind, Placebo‐Controlled Study
Storey, J. R., Calder, C. S., Hart, D. E., & Potter, D. L. (2001) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.01190.x · Cited by 196
Patterns of health care utilization for migraine in England and in the United States
Lipton, R. B., Scher, A. I., Steiner, T. J., Bigal, M. E., Kolodner, K., Liberman, J. N., & Stewart, W. F. (2003) · Neurology · doi:10.1212/wnl.60.3.441 · Cited by 175
Self-citation
Cited by
EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force
Evers, S., Áfra, J., Frese, A., Goadsby, P. J., Linde, M., May, A., & Sándor, P. S. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02748.x · Cited by 892
Holland, S., Silberstein, S. D., Freitag, F., Dodick, D. W., Argoff, C., & Ashman, E. (2012) · Neurology · doi:10.1212/wnl.0b013e3182535d0c · Cited by 347
Differential Effectiveness of Placebo Treatments: A Systematic Review of Migraine Prophylaxis
Meissner, K., Fässler, M., Rücker, G., Kleijnen, J., Hróbjartsson, A., Schneider, A., Antes, G., & Linde, K. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.10391 · Cited by 301
Nonpharmacologic Treatments for Migraine and Tension-Type Headache: How to Choose and When to Use
Nicholson, R. A., Buse, D. C., Andrasik, F., & Lipton, R. B. (2011) · Current Treatment Options in Neurology · doi:10.1007/s11940-010-0102-9 · Cited by 88
Self-citationHaag, G., Diener, H.-C., May, A., Meyer, C., Morck, H., Straube, A., Wessely, P., & Evers, S. (2011) · The Journal of Headache and Pain · doi:10.1007/s10194-010-0266-4 · Cited by 78
Metadata
- Authors
- Lipton, R. B., Göbel, H., Einhäupl, K. M., Wilks, K., & Mauskop, A.
- Venue
- Neurology
- Published
- 2004-12-28
- Volume
- 63
- Issue
- 12
- Pages
- 2240-2244
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2087174976
- Cited by
- 254
- References
- 19
- FWCI
- 10.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. https://app.cochat.ai/papers/10.1212/01.wnl.0000147290.68260.11
- The paper
- Lipton, R. B., Göbel, H., Einhäupl, K. M., Wilks, K., & Mauskop, A. (2004). Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology. https://doi.org/10.1212/01.wnl.0000147290.68260.11
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.